Suso Platero

Dr. Suso Platero leads the Biomarker Solution Center, providing clients with biomarker consultation and strategy that leverages both Covance and LabCorp laboratories resources to aid in the development of biomarker delivery. He draws on 20+ years of experience with contract research organizations, diagnostic and pharmaceutical industries and academia, as well as with federal agencies and key opinion leaders in oncology and immuno-oncology.

Dr. Platero has contributed to the discovery of biomarkers and their application in clinical trials as well as the development of biomarkers to support companion diagnostics (CDx) and recently helped develop a companion diagnostic for a drug that was approved by the FDA in 2019. He served as the editor of the book, Molecular Pathology in Drug Discovery and Development, has authored numerous articles and holds four U.S. patents.